ResearcherWenzhou Medical UniversityNo recent work listed

Haibo Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1506-2346; OpenAlex author ID A5039169614. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Intratumour microbiome of pancreatic cancer. Last author DOI 10.4251/wjgo.v15.i5.713 ↗
Down-regulation of MiR-539 Indicates Poor Prognosis in Patients with Pancreatic Cancer. Co-author DOI 10.1515/biol-2018-0059 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shiwei Guan · 1 shared paper, 2023 · strength 0.31
- Paper Intratumour microbiome of pancreatic cancer. DOI 10.4251/wjgo.v15.i5.713 ↗
Quan Lin · 1 shared paper, 2023 · strength 0.31
- Paper Intratumour microbiome of pancreatic cancer. DOI 10.4251/wjgo.v15.i5.713 ↗
Wu Ji · 1 shared paper, 2018 · strength 0.12
- Paper Down-regulation of MiR-539 Indicates Poor Prognosis in Patients with Pancreatic Cancer. DOI 10.1515/biol-2018-0059 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.